Today, one of Amgen's (nasdaq: AMGN - news - people ) side-effect drugs, Neulasta, is getting a boost as researchers present data at the MultinationalAssociationofSupportiveCareinCancer annual meeting in Miami showing that it can reduce infections brought on by chemotherapy -- and the hospitalizations that result -- by more than 90%.